The Relationship Between Naturalistic Psychedelic Use and Clinical Care in Canada
Nicolas G. Glynos, Daniel J. Kruger, Nicholas Kolbman, Kevin F. Boehnke, Philippe Lucas
Journal of Psychoactive Drugs July 29, 2023 DOI: 10.1080/02791072.2023.2242353 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 2,384 |
| Population | Canadian adults reporting past use of a psychedelic |
| Key findings | Most Canadians who have used psychedelics (81.2%) never discussed that use with their health care provider, despite a third using them for self-treatment. |
Abstract
ABSTRACT Naturalistic psychedelic use among Canadians is common. However, interactions about psychedelic use between patients and clinicians in Canada remain unclear. Via an anonymous survey, we assessed health outcomes and integration of psychedelic use with health care providers (HCP) among Canadian adults reporting past use of a psychedelic. The survey included 2,384 participants, and most (81.2%) never discussed psychedelic use with their HCP. While 33.7% used psychedelics to self-treat a health condition, only 4.4% used psychedelics with a therapist and 3.6% in a clinical setting. Overall, 44.8% (n = 806) of participants were aware of substance testing services, but only 42.4% ever used them. Multivariate regressions revealed that therapeutic motivation, higher likelihood of seeking therapist guidance, and non-binary gender identification were significantly associated with higher odds of discussing psychedelics with one’s primary HCP. Having used a greater number of psychedelics, lower age, non-female gender, higher education, and a therapeutic motivation were significantly associated with higher odds of awareness of substance testing. We conclude that naturalistic psychedelic use in Canada often includes therapeutic goals but is poorly connected to conventional healthcare, and substance testing is uncommon. Relevant training and education for HCPs is needed, along with more visible options for substance testing.